Doximity Inc. shares rose 3.4% during Thursday morning trading, moving against a weaker U.S. equity market. No company announcement or analyst action was identified as the catalyst for the session's gain.

The stock has recovered from an all-time low of $17.15 reached in May 2026. The advance occurred while broader U.S. equity markets declined, suggesting stock-specific buying rather than market-wide momentum.

In late September, Doximity announced its Ask AI assistant ranked first against frontier models in an independent evaluation by Fireworks as part of a new cross-industry Specialized Intelligence Index. A separate study conducted by Stanford and Harvard in July also placed the tool ahead of other U.S.-based clinical AI models.

Evercore ISI lowered its price target on the stock to $35 from $40 in late September. The consensus rating across approximately 21 analysts stands at Hold, with an average price target near $29.